Clinical Trial Update: A Study Evaluating INIPARIB in Combination With Chemotherapy to Treat Triple Negative Breast Cancer Brain Metastasis [Phase 2]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 2 study evaluating INIPARIB in combination with chemotherapy for triple-negative breast cancer with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Triple-negative Breast Cancer

Drugs mentioned

• Iniparib (iparib)

Snippet

Sponsor: Sanofi | Conditions: Estrogen Receptor Negative (ER-Negative) Breast Cancer, Progesterone Receptor Negative (PR-Negative) Breast Cancer | Phase 2 | Status: COMPLETED